基于人群的结肠胶囊内镜胃肠道异常患病率研究
该研究从鹿特丹研究中纳入50-75岁参与者,2017-2019年接受结肠胶囊内镜(CCE)检查,分析451份视频。99.3%参与者至少发现1处异常,临床相关异常患病率为12%,其中结肠占10.2%,小肠占1.1%,食管/胃占0.7%。
要点
- 无症状人群CCE下胃肠道异常极为常见,任何异常达99.3%。
- 临床相关异常总患病率为12%,以结肠病变(10.2%)为主。
- 结肠最常见异常为憩室(81.2%),小肠为糜烂(23.8%)。
核心结论
- 在基本无症状的西方人群中,胃肠道病变非常常见,CCE下临床相关病变患病率为12%。
研究设计与样本
- 研究从鹿特丹研究(纵向流行病学研究)中选取2017-2019年50-75岁参与者,行CCE检查并分析视频。
- 共邀请2800名受试者,462名(16.5%)摄入结肠胶囊,最终分析451份视频。
主要发现
- 448名(99.3%)参与者至少发现1处异常。
- 各胃肠段异常患病率:食管14.8%(Barrett食管<3cm占8.3%),胃27.9%(胃底腺息肉占18.1%),小肠33.9%(糜烂占23.8%),结肠93.3%(憩室占81.2%)。
- 54名(12%)参与者存在临床相关异常:食管/胃3名(0.7%),小肠5名(1.1%,息肉>10mm者4例、严重溃疡1例),结肠46名(10.2%,息肉>10mm或≥3枚息肉46例、结直肠癌1例)。
关键数值与推荐
- 临床相关异常定义为:Barrett段>3cm、严重溃疡、小肠或结肠息肉>10mm或≥3枚息肉、癌症。
- 94.7%的胶囊到达降结肠。
临床怎么用
- 本研究为一般人群胃肠道病变患病率提供了参考框架,提示无症状人群中也存在不可忽视的临床相关病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The population prevalence of gastrointestinal (GI) disease is unclear and difficult to assess in an asymptomatic population. The aim of this study was to determine prevalence of GI lesions in a largely asymptomatic population undergoing colon capsule endoscopy (CCE). METHODS: Participants aged between 50-75 years were retrieved from the Rotterdam Study, a longitudinal epidemiological study, between 2017-2019. Participants received CCE with bowel preparation. Abnormalities defined as clinically relevant were Barrett segment >3cm, severe ulceration, polyp >10 mm or ≥3 polyps in small bowel (SB) or colon, and cancer. RESULTS: Of 2800 invited subjects, 462 (16.5%) participants (mean age 66.8 years, female 53.5%) ingested the colon capsule. A total of 451 videos were analyzed, and in 94.7% the capsule reached the descending colon. At least 1 abnormal finding was seen in 448 (99.3%) participants. The prevalence of abnormalities per GI segment, and the most common type of abnormality, were as follows: Esophageal 14.8% (Barrett's esophagus <3 cm in 8.3%), gastric 27.9% (fundic gland polyps in 18.1%), SB abnormalities 33.9% (erosions in 23.8%), colon 93.3% (diverticula in 81.2%). A total of 54 participants (12%) had clinically relevant abnormalities, 3 (0.7%) in esophagus/stomach (reflux esophagitis grade D, Mallory Weiss lesion and severe gastritis), 5 (1.1%) in SB (polyps > 10 mm; n = 4, severe ulcer n = 1,) and 46 (10.2%) in colon (polyp > 10 mm or ≥3 polyps n = 46, colorectal cancer n = 1). CONCLUSIONS: GI lesions are very common in a mostly asymptomatic Western population, and clinically relevant lesions were found in 12% at CCE. These findings provide a frame of reference for the prevalence rates of GI lesions in the general population.
引用
- Vuik FER, Nieuwenburg SAV, Moen S, et al. Population-Based Prevalence of Gastrointestinal Abnormalities at Colon Capsule Endoscopy. Clin Gastroenterol Hepatol. 2020. PMID: 33130189. doi:10.1016/j.cgh.2020.10.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。